Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2023

Aug 24, 2023

30786_dirs_2023-08-23_6e7595c9-7081-4cab-8ec4-56d02cf0b727.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-08-23

Reporting Person: ERNST TIMOTHY S (EVP, General Counsel & Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-08-23 Bio-Rad A Common Stock S 300 $384.69 Disposed 2415.7965 Direct

Footnotes

F1: Includes 19.319 and 25.114 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 3/31/2023 and 06/30/2023, respectively.